Abstract
This study analyzes the link between temperatures and COVID-19 contagions in a sample of Italian regions during the period ranging from February 24 to April 15. To that end, Bayesian Model Averaging techniques are used to analyze the relevance of the temperatures together with a set of additional climate, environmental, demographic, social and policy factors. The robustness of individual covariates is measured through posterior inclusion probabilities. The empirical analysis provides conclusive evidence on the role played by the temperatures given that it appears as the most relevant determinant of contagions. This finding is robust to (i) the prior distribution elicitation, (ii) the procedure to assign weights to the regressors, (iii) the presence of measurement errors in official data due to under-reporting, (iv) the employment of different metrics of temperatures or (v) the inclusion of additional correlates. In a second step, relative importance metrics that perform an accurate partitioning of the R2 of the model are calculated. The results of this approach support the evidence of the model averaging analysis, given that temperature is the top driver explaining 45% of regional contagion disparities. The set of policy-related factors appear in a second level of importance, whereas factors related to the degree of social connectedness or the demographic characteristics are less relevant.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research has benefited from the financial support of the Spanish Ministry of Economy and Competitiveness (Project ECO2016-76681-R).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† Department of Economics and Management, University of Pisa, Cosimo Ridolfi 10, 56124, Pisa, Italy. lisa.gianmoena{at}unipi.it
Data Availability
The data, MATLAB and R codes can be provided upon request.
